Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Tong, Frank	Vanderbilt University United States	Learning the visual and cognitive bases of lung nodule detection	5R01CA240274-05
Toriola, Adetunji T	Washington University United States	Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention	5R37CA235602-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	5R01CA285980-02	Guillermo Marquez, Ph.D.
Tussing-Humphreys, Lisa	University Of Illinois At Chicago United States	Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity	5R01CA257807-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Tussing-Humphreys, Lisa	University Of Illinois At Chicago United States	Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity	5R01CA257807-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Ulrich, Cornelia M	University Of Utah United States	Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link	5R01CA254108-05	Asad Umar, D.V.M., Ph.D.
Upshaw, Jenica	Beth Israel Deaconess Medical Center United States	A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure	1R37CA300969-01	Eileen Dimond, R.N., M.S.
Valdimarsdottir, Heiddis	Icahn School Of Medicine At Mount Sinai United States	Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation	5R01CA260961-04	Marjorie Perloff, M.D.
Veiseh, Omid	Rice University United States	Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema	1R01HL179534-01	Goli Samimi, Ph.D., M.P.H.
Velculescu, Victor E.	Johns Hopkins University United States	DNA evaluation of fragments for early interception (DELFI) of Lung cancer	5U01CA271896-03	Guillermo Marquez, Ph.D.
Vijayvergia, Namrata	Research Inst Of Fox Chase Can Ctr United States	Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study	1R21CA292276-01A1	Rachel Altshuler, Ph.D.
Villanueva, Augusto	Icahn School Of Medicine At Mount Sinai United States	Liquid biopsy and radiomics for liver cancer surveillance	4U01CA283931-03	Sidney Fu, M.D.
Vinciguerra, Vincent P	Feinstein Institute For Medical Research United States	Northwell Health NCORP	3UG1CA189850-11S2	Vanessa A. White, M.P.H.
Wagner, Lynne I.	Ecog-Acrin Medical Research Foundation United States	ECOG-ACRIN NCORP Research Base	3UG1CA189828-11S2	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wallace, Douglas C	Children'S Hosp Of Philadelphia United States	Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA	5R01CA259635-04	Young Kim, Ph.D.